DiaSorin S.p.A. (BIT:DIA)
Italy
· Delayed Price · Currency is EUR 75.06
+0.92 (1.24%)
Sep 29, 2025, 2:43 PM CET
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Italy Operating Profit | 104.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Italy Operating Profit Growth | -22.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Operating Profit | 24.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Operating Profit Growth | 0.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Operating Profit | 140.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Operating Profit Growth | -27.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Operating Profit | 1.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Operating Profit Growth | -1957.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Operating Profit | -12.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Operating Profit Growth | -204.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Italy | 176.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Italy Growth | -11.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 288.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 4.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 618.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -16.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 101.81M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | -9.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Ex-COVID Immunodiagnostics % of Revenue | 66.20 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ex-COVID Immunodiagnostics % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ex-COVID Molecular Diagnostics % of Revenue | 17.20 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ex-COVID Molecular Diagnostics % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licensed Technologies % of Revenue | 14.40 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licensed Technologies % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID % of Revenue | 2.20 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|